US2004002103A1PendingUtilityA1

Synthetic ligation reassembly in directed evolution

Priority: Jun 14, 1999Filed: Apr 24, 2003Published: Jan 1, 2004
Est. expiryJun 14, 2019(expired)· nominal 20-yr term from priority
Inventors:Jay M. Short
A61P 33/06C12N 9/14A61K 2039/53C12N 15/1027C07K 14/445C12N 15/102C12N 15/1058C12N 15/1034A61K 39/00C12Y 308/01002
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Harvesting the full richness of biodiversity is instantly recognized by Diversa Corporation as a powerful means to access both novel molecules having direct commercial utility as well as molecular templates that could be retooled to acquire commercial utility. A directed evolution process for rapid and facilitated production from a progenitor polynucleotide template, of a library of mutagenized progeny polynucleotides wherein each of the 20 naturally encoded amino acids is encoded at each original codon position. This method, termed site-saturation mutagenesis, or simply saturation mutagenesis, is preferably based on the use of the degenerate N,N,G/T sequence. Also, a method of non-stochastically producing a library of chimeric nucleic acid molecules having an overall assembly order that is chosen by design. Accordingly, a set of progenitor templates, such as genes (e.g. a family of esterase genes) or genes pathways (e.g. encoding antibiotics) can be shuffled to generate a sizable library of distinct progeny polynucleotide molecules (e.g. 10 100 ) and correspondingly encoded polypeptides. Screening of these polynucleotide libraries enables the identification of a desirable molecular species that has a desirable property, such as a specific enzymatic activity serviceable for a commercial application, or a novel antibiotic. Also, a method of retooling genes and gene pathways by the introduction of regulatory sequences, such as promoters, that are operable in an intended host, thus conferring operability to a novel gene pathway when it is introduced into an intended host. For example a novel man-made gene pathway, generated based on microbially-derived progenitor templates, that is operable in a plant cell.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method of non-stochastically producing a library of chimeric nucleic acid molecules having an overall assembly order that is non-random comprising: 
 (a) non-randomly generating a plurality of nucleic acid building blocks having mutually compatible ligatable ends; and    (b) assembling the nucleic acid building blocks, such that a designed overall assembly order is achieved;    whereby a set of progenitor templates can be shuffled to generate a library of progeny polynucleotide molecules and correspondingly encoded polypeptides, and    whereby screening of the progeny polynucleotide library provides a means to identify a desirable species that have a desirable property.    
     
     
         2 . A method of non-stochastically producing a library comprised of a defined number of groupings comprised of one or more groupings of chimeric nucleic acid molecules having an overall assembly order that is chosen by design, said method comprised of: 
 (a) generating by design for each grouping a set of specific nucleic acid building blocks having serviceable mutually compatible ligatable ends, and    (b) assembling these nucleic acid building blocks according to said groupings, such that a designed overall assembly order is achieved;    whereby a set of progenitor templates can be shuffled to generate a library of progeny polynucleotide molecules and correspondingly encoded polypeptides, and    whereby the expression screening of the progeny polynucleotide library provides a means to identify a desirable species that has a desirable property.

Join the waitlist — get patent alerts

Track US2004002103A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.